| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966083 | Vaccine | 2014 | 5 Pages |
Abstract
Although most participants had anti-Hib antibody above concentrations putatively defined as protective, significantly fewer had concentrations thought to confer long-term protection. This suggests a population with insufficient or waning antibody that may be susceptible to breakthrough disease and transmission.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
O.T. Idoko, E. Roberts, M. Cox, J. Jafali, J. Njie-Jobe, G. Mackenzie, M.O. Ota, B. Kampmann,
